Indicated for: diagnostic imaging contrast enhancement
Route of administration: infusion
Substance: mangafodipir (contrast agent)
ATC: V08CA05 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Mangafodipir is a contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of the liver and other abdominal structures. It contains manganese, which helps improve MRI image clarity by altering the magnetic signal of tissues.
This contrast agent is administered intravenously and is primarily used to detect liver lesions, tumors, or other abnormalities. The procedure is performed under the supervision of a medical imaging specialist.
Although mangafodipir is generally well-tolerated, it may cause side effects such as nausea, headaches, or injection site reactions. In rare cases, severe allergic reactions may occur.
Patients with kidney conditions or known allergies to contrast agents should inform their doctor before the procedure. Pregnant or breastfeeding women should discuss the risks and benefits of using this contrast agent with a specialist.